Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab.

Mogensen TH, Bernth-Jensen JM, Petersen CC, Petersen MS, Nyvold C, Gadegaard KH, Hokland M, Hokland P, Larsen CS.

BMC Hematol. 2013 Apr 11;13(1):4. doi: 10.1186/2052-1839-13-4.

2.

[Recurrent infections in an ITP patient treated with rituximab].

Rosenberg-Bezalel S, Asher I, Sthoeger Z.

Harefuah. 2012 Nov;151(11):617-9, 655. Hebrew.

PMID:
23367730
3.

Common variable immunodeficiency, immune thrombocytopenia, rituximab and splenectomy: important considerations.

Arays R, Goyal S, Jordan KM.

Postgrad Med. 2016 Aug;128(6):567-72. doi: 10.1080/00325481.2016.1199250. Epub 2016 Jun 23.

PMID:
27276370
4.

[Primary immunodeficiencies presenting with autoimmune cytopenias in adults].

Sève P, Broussolle C, Pavic M.

Rev Med Interne. 2013 Mar;34(3):148-53. doi: 10.1016/j.revmed.2012.05.007. Epub 2012 Jun 15. Review. French.

PMID:
22703729
5.

[Atypical presentation of common variable immunodeficiency without infections].

Carbone J, Sarmiento E, Rodríguez-Molina JJ, Fernández-Cruz E.

Allergol Immunopathol (Madr). 2004 Jul-Aug;32(4):218-22. Spanish.

PMID:
15324652
6.

[Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].

Toubi E.

Harefuah. 2012 Nov;151(11):620-1, 655. Hebrew.

PMID:
23367731
7.

Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.

Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, Sarmiento E, Micheloud D, Fernandez-Cruz E.

Ann N Y Acad Sci. 2005 Jun;1051:666-71.

PMID:
16127007
8.

Successful Treatment of ANCA-Associated Vasculitis in the Setting of Common Variable Immunodeficiency Using Rituximab.

Hill F, Yonkof J, Chaitanya Arudra SK, Thomas J, Altorok N.

Am J Ther. 2016 Sep-Oct;23(5):e1239-45. doi: 10.1097/MJT.0000000000000323.

PMID:
26291596
9.

Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature.

Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, Oksenhendler E, Schaeffer A, Bierling P, Godeau B.

Medicine (Baltimore). 2004 Jul;83(4):254-63. Review.

10.

Diagnostic and therapeutic considerations in patients with hypogammaglobulinemia after rituximab therapy.

Kado R, Sanders G, McCune WJ.

Curr Opin Rheumatol. 2017 May;29(3):228-233. doi: 10.1097/BOR.0000000000000377. Review.

PMID:
28240614
11.

Rituximab and immune deficiency: case series and review of the literature.

Kaplan B, Kopyltsova Y, Khokhar A, Lam F, Bonagura V.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):594-600. doi: 10.1016/j.jaip.2014.06.003. Epub 2014 Aug 7. Review.

PMID:
25213054
12.

Successful use of rituximab in refractory idiopathic thrombocytopenic purpura in a patient with common variable immunodeficiency.

Al-Ahmad M, Al-Rasheed M, Al-Muhani A.

J Investig Allergol Clin Immunol. 2010;20(3):259-62.

13.

Autoimmune cytopenias in common variable immunodeficiency.

Podjasek JC, Abraham RS.

Front Immunol. 2012 Jul 24;3:189. doi: 10.3389/fimmu.2012.00189. eCollection 2012.

14.

Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients.

Gobert D, Bussel JB, Cunningham-Rundles C, Galicier L, Dechartres A, Berezne A, Bonnotte B, DeRevel T, Auzary C, Jaussaud R, Larroche C, LeQuellec A, Ruivard M, Seve P, Smail A, Viallard JF, Godeau B, Hermine O, Michel M.

Br J Haematol. 2011 Nov;155(4):498-508. doi: 10.1111/j.1365-2141.2011.08880.x. Epub 2011 Oct 8.

15.

Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.

Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, Jayne DR.

J Autoimmun. 2015 Feb;57:24-9. doi: 10.1016/j.jaut.2014.11.004. Epub 2015 Jan 10.

PMID:
25586449
16.

Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma.

Rael E, Rakszawski K, Koller K, Bayerl M, Butte M, Zheng H.

Biomark Res. 2016 Mar 9;4:7. doi: 10.1186/s40364-016-0061-8. eCollection 2016.

17.

Clinical and immunological features of common variable immunodeficiency in Mexican patients.

Ramírez-Vargas N, Arablin-Oropeza SE, Mojica-Martínez D, Yamazaki-Nakashimada MA, de la Luz García-Cruz M, Terán-Juárez LM, Cortés-Grimaldo RM, Torres-Lozano C, Madrigal-Beas I, Ortega-Cisneros M, Vargas-Camaño ME, Staines-Boone T, Pietropaolo-Cienfuegos D, Berrón-Ruiz L, Espinosa-Rosales FJ, Guevara-Cruz M, Blancas-Galicia L.

Allergol Immunopathol (Madr). 2014 May-Jun;42(3):235-40. doi: 10.1016/j.aller.2013.01.007. Epub 2013 Apr 8.

PMID:
23578780
18.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.

Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.

Am J Hematol. 2005 Apr;78(4):275-80.

19.

Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.

Levy R, Mahévas M, Galicier L, Boutboul D, Moroch J, Loustau V, Guillaud C, Languille L, Fain O, Bierling P, Khellaf M, Michel M, Oksenhendler E, Godeau B.

Autoimmun Rev. 2014 Oct;13(10):1055-63. doi: 10.1016/j.autrev.2014.08.036. Epub 2014 Aug 27. Review.

PMID:
25183241
20.

[Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].

Lehembre S, Macario-Barrel A, Musette P, Carvalho P, Joly P.

Ann Dermatol Venereol. 2006 Jan;133(1):53-5. French.

PMID:
16495854

Supplemental Content

Support Center